Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.

We have generated mouse models of human Tay-Sachs and Sandhoff diseases by targeted disruption of the Hexa (alpha subunit) or Hexb (beta subunit) genes, respectively, encoding lysosomal beta-hexosaminidase A (structure, alpha) and B (structure, beta beta). Both mutant mice accumulate GM2 ganglioside in brain, much more so in Hexb -/- mice, and the latter also accumulate glycolipid GA2. Hexa -/- mice suffer no obvious behavioral or neurological deficit, while Hexb -/- mice develop a fatal neurodegenerative disease, with spasticity, muscle weakness, rigidity, tremor and ataxia. The Hexb -/- but not the Hexa -/- mice have massive depletion of spinal cord axons as an apparent consequence of neuronal storage of GM2. We propose that Hexa -/- mice escape disease through partial catabolism of accumulated GM2 via GA2 (asialo-GM2) through the combined action of sialidase and beta-hexosaminidase B.

[1]  Michael P. McDonald,et al.  Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism , 1995, Nature Genetics.

[2]  E. Snyder,et al.  Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain , 1995, Nature.

[3]  L. Riboni,et al.  The Degradative Pathway of Gangliosides GM1 and GM2 in Neuro2a Cells by Sialidase , 1995, Journal of neurochemistry.

[4]  A. Lamhonwah,et al.  Structural organization, sequence, and expression of the mouse HEXA gene encoding the alpha subunit of hexosaminidase A. , 1994, Genomics.

[5]  J. Trasler,et al.  Characterization of the murine -hexosaminidase (HEXB) gene , 1994 .

[6]  J. Månsson,et al.  Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. , 1994, Biochimica et biophysica acta.

[7]  K Suzuki,et al.  Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Neuwelt,et al.  Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). , 1994, The American journal of pathology.

[9]  K. Shitara,et al.  Chimeric anti-ganglioside GM2 antibody with antitumor activity. , 1994, Cancer research.

[10]  J. Roder,et al.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J L Stirling,et al.  Cloning and sequence analysis of a cDNA encoding the alpha-subunit of mouse beta-N-acetylhexosaminidase and comparison with the human enzyme. , 1992, The Biochemical journal.

[12]  R. Hawkes,et al.  The modular cerebellum , 1991, Progress in Neurobiology.

[13]  H. J. Baker,et al.  Neuroaxonal dystrophy in neuronal storage disorders: Evidence for major GABAergic neuron involvement , 1991, Journal of the Neurological Sciences.

[14]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[15]  G. Brewer,et al.  Gangliosides and synaptic transmission. , 1990, Biochimica et biophysica acta.

[16]  S. Tsuiki,et al.  Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain. , 1990, Journal of biochemistry.

[17]  D. Mahuran.  Characterization of human placental beta-hexosaminidase I2. Proteolytic processing intermediates of hexosaminidase A. , 1990, The Journal of biological chemistry.

[18]  H. J. Baker,et al.  Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. , 1990, Brain research. Developmental brain research.

[19]  C. Schengrund.  The role(s) of Gangliosides in neural differentiation and repair: A perspective , 1990, Brain Research Bulletin.

[20]  H. Yamada,et al.  Characterization of mouse liver sialidase and partial purification of the lysosomal sialidase. , 1988, Chemical and pharmaceutical bulletin.

[21]  D. Mahuran,et al.  Cloning and sequence analysis of a cDNA encoding the β‐subunit of mouse β‐hexosaminidase , 1988 .

[22]  T. Beccari,et al.  Identification of beta-N-acetylhexosaminidase A in mouse tissues with the fluorigenic substrate 4-methylumbelliferyl-beta-N-acetylglucosamine 6-sulphate. , 1988, The Biochemical journal.

[23]  R. Geyer,et al.  Glycosphingolipid composition of human semen. , 1987, Archives of biochemistry and biophysics.

[24]  H. Willard,et al.  Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). , 1986, The Journal of biological chemistry.

[25]  J. Stirling,et al.  Purification and characterization of beta-N-acetylhexosaminidase I2 from human liver. , 1986, Biochemical Journal.

[26]  R. Ledeen.  Gangliosides of the neuron , 1985, Trends in Neurosciences.

[27]  W. Johnson,et al.  Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. , 1985, The Journal of clinical investigation.

[28]  K. Sandhoff,et al.  Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. , 1985, The Journal of biological chemistry.

[29]  H. Rösner,et al.  Topographical Atlas of the Gangliosides of the Adult Human Brain , 1984, Journal of neurochemistry.

[30]  K. Sandhoff,et al.  Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[31]  N. Kin,et al.  Deficiency of the Hexosaminidase A Activator Protein in a Case of GM2 Gangliosidosis; Variant AB , 1982, Pediatric Research.

[32]  S. Kosanke,et al.  Clinical and Biochemical Abnormalities in Porcine GM2-Gangliosidosis , 1978, Veterinary pathology.

[33]  K. Sandhoff,et al.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Arnon,et al.  Immunochemical and biochemical investigation of hexosaminidase S. , 1977, American journal of human genetics.

[35]  H. J. Baker,et al.  GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. , 1977, Science.

[36]  K. Sandhoff,et al.  ENZYME ALTERATIONS AND LIPID STORAGE IN THREE VARIANTS OF TAY‐SACHS DISEASE , 1971, Journal of neurochemistry.

[37]  E. Karbe,et al.  Familial Amaurotic Idiocy in Male German Shorthair Pointers , 1967, Pathologia veterinaria.

[38]  J. Trasler,et al.  Characterization of the murine beta-hexosaminidase (HEXB) gene. , 1994, Biochimica et Biophysica Acta.

[39]  A. Joyner,et al.  Production of targeted embryonic stem cell clones. , 1993 .

[40]  A. Joyner,et al.  Production of chimeras and genetically defined offspring from targeted ES cells. , 1993 .

[41]  Alexandra L. Joyner,et al.  Gene targeting: a practical approach. , 1993 .

[42]  D. Mahuran,et al.  Cloning and sequence analysis of a cDNA encoding the beta-subunit of mouse beta-hexosaminidase. , 1988, FEBS Letters.

[43]  K. Suzuki.  Enzymatic diagnosis of sphingolipidoses. , 1987, Methods in enzymology.

[44]  L. Svennerholm.  Gangliosides and synaptic transmission. , 1980, Advances in experimental medicine and biology.

[45]  T. Momoi,et al.  Separation and micro-detection of oligosaccharides of glycosphingolipids by high performance cellulose thin-layer chromatography-autoradiofluorography. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[46]  P. Mandel,et al.  Structure and Function of Gangliosides , 1980, Advances in Experimental Medicine and Biology.

[47]  K. Sandhoff,et al.  Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. , 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[48]  M. Adachi,et al.  Ultrastructural studies of eight cases of fetal Tay-Sachs disease. , 1974, Laboratory investigation; a journal of technical methods and pathology.